Published in Hum Mol Genet on September 21, 2010
The genetics of hyperuricaemia and gout. Nat Rev Rheumatol (2012) 1.47
Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep (2013) 1.28
Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis (2012) 1.26
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study. Am J Epidemiol (2013) 1.03
Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. PLoS One (2014) 0.99
Racial and gender disparities among patients with gout. Curr Rheumatol Rep (2013) 0.98
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. Int J Cancer (2011) 0.95
The population pharmacokinetics of allopurinol and oxypurinol in patients with gout. Eur J Clin Pharmacol (2013) 0.90
Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin North Am (2014) 0.90
Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Res Ther (2013) 0.89
Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther (2013) 0.89
The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity. Arthritis Res Ther (2011) 0.86
The association between the polymorphism rs2231142 in the ABCG2 gene and gout risk: a meta-analysis. Clin Rheumatol (2014) 0.86
The pharmacokinetics of oxypurinol in people with gout. Br J Clin Pharmacol (2012) 0.85
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge. Arthritis Res Ther (2014) 0.83
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Res Ther (2015) 0.83
Predicting allopurinol response in patients with gout. Br J Clin Pharmacol (2015) 0.83
The experience and impact of gout in Māori and Pacific people: a prospective observational study. Clin Rheumatol (2012) 0.82
Gout, genetics and ABC transporters. F1000 Biol Rep (2011) 0.78
Hyperuricaemia in the Pacific: why the elevated serum urate levels? Rheumatol Int (2013) 0.77
A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk. Int J Clin Exp Pathol (2015) 0.76
No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets. Rheumatology (Oxford) (2012) 0.75
Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A. BMC Med Genet (2016) 0.75
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med (2017) 0.75
Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Res Ther (2017) 0.75
Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout. Rheumatol Int (2015) 0.75
Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong. Per Med (2016) 0.75
ABCG2 Polymorphism Is Associated with Hyperuricemia in a Study of a Community-Based Korean Cohort. J Korean Med Sci (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) (2012) 5.22
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J (2012) 2.37
Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol (2009) 2.14
Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.99
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77
TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J Gastroenterol Hepatol (2007) 1.70
A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med (2010) 1.60
Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout. Rheumatology (Oxford) (2012) 1.57
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease. Respirology (2012) 1.49
Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum (2005) 1.48
Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population. J Rheumatol (2013) 1.45
Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology (Oxford) (2016) 1.38
Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxford) (2009) 1.34
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum (2009) 1.32
IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol (2007) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) (2012) 1.30
Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum (2003) 1.27
The gouty tophus: a review. Curr Rheumatol Rep (2015) 1.26
Outcome domains for studies of acute and chronic gout. J Rheumatol (2009) 1.24
The genetic basis of hyperuricaemia and gout. Joint Bone Spine (2010) 1.20
Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med (2006) 1.20
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum (2011) 1.18
Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis. J Rheumatol (2009) 1.15
Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab (2007) 1.13
A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet (2013) 1.10
Developing a provisional definition of flare in patients with established gout. Arthritis Rheum (2012) 1.10
Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol (2011) 1.10
Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis (2013) 1.08
'Choosing shoes': a preliminary study into the challenges facing clinicians in assessing footwear for rheumatoid patients. J Foot Ankle Res (2010) 1.08
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Clinical audit of foot problems in patients with rheumatoid arthritis treated at Counties Manukau District Health Board, Auckland, New Zealand. J Foot Ankle Res (2009) 1.07
Progress in measurement instruments for acute and chronic gout studies. J Rheumatol (2009) 1.06
Imaging in gout--what can we learn from MRI, CT, DECT and US? Arthritis Res Ther (2011) 1.06
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis (2013) 1.04
Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. Atherosclerosis (2011) 1.02
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum (2007) 1.02
Functional and biomechanical characteristics of foot disease in chronic gout: A case-control study. Clin Biomech (Bristol, Avon) (2010) 1.00
Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet (2012) 1.00
Maternal psychological reaction to newborn genetic screening for type 1 diabetes. Pediatrics (2007) 1.00
A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. Rheumatology (Oxford) (2009) 0.99
Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study. Arthritis Care Res (Hoboken) (2012) 0.99
The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol (2011) 0.98
Imaging of gout: findings and utility. Arthritis Res Ther (2009) 0.98
A review of uric acid, crystal deposition disease, and gout. Adv Ther (2014) 0.97
Predicting joint damage in rheumatoid arthritis using MRI scanning. Arthritis Res Ther (2009) 0.97
Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2011) 0.96
KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population. Am J Gastroenterol (2010) 0.95
A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells. Clin Pharmacokinet (2013) 0.95
Gout--what are the treatment options? Expert Opin Pharmacother (2009) 0.94
Bone erosions in patients with chronic gouty arthropathy are associated with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study. Rheumatology (Oxford) (2013) 0.93
Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography. Arthritis Res Ther (2012) 0.93
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol (2011) 0.92
Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort. Immunol Cell Biol (2006) 0.92
Assessment of cartilage loss at the wrist in rheumatoid arthritis using a new MRI scoring system. Ann Rheum Dis (2010) 0.92
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation. Br J Clin Pharmacol (2010) 0.92
Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Res Ther (2010) 0.92